– USA, NJ – Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has appointed Thomas J. Sabatino, Jr. to its Board of Directors. Mr. Sabatino will also serve on the Company’s Audit Committee.
Jason Grenfell-Gardner, President and CEO of the Company, commented, “We are excited that Tom has agreed to join our Board of Directors. His extensive experience in the various aspects of the pharmaceutical industry, including experience in manufacturing, wholesale and retail distribution, as well as his most recent experience on the payor side of the business, will be a valuable asset to Teligent and its Board of Directors.” Mr. Grenfell-Gardner continued, “We look forward to working with Tom, as we continue to execute our TICO strategy, focused on the topical, injectable, complex and ophthalmic generic pharmaceutical markets.”
Mr. Sabatino is currently Executive Vice President and General Counsel of Aetna. He is the Chief Legal Officer of the company with worldwide responsibility for leading its legal operations, including formulating corporate legal policy. In addition, he oversees the Corporate Secretary and Compliance functions. He is a member of the Executive Committee, the senior governing body of the Company.
Mr. Sabatino joined Aetna from Hertz Global Holdings, Inc., where he served as Senior Executive Vice President, Chief Administrative Officer and General Counsel. He joined Hertz in 2015 after serving as Executive Vice President, Global Legal and Chief Administrative Officer of Walgreens Boots Alliance. Previously, in 2010, Mr. Sabatino was Executive Vice President and General Counsel of UAL Corporation and United Airlines, Inc., and was Executive Vice President and General Counsel of Schering-Plough Corporation from 2004 through 2009. He also has held General Counsel positions at Baxter International and American Medical International.
Mr. Sabatino earned his law degree from the University of Pennsylvania and his undergraduate degree from Wesleyan University in Connecticut.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market.
For more information : http://www.teligent.com
- Disclaimer - News, data and statement included in this release are intended exclusively for general information purposes. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of the information. No data or statement in this release should be considered for decisions about securities referred. Product and brand names used in this release maybe trademarks or registered trademarks of their respective owners.
Comments are closed.